Paul B. Freeman OD, FAAO, FOVDR
Chief, Low Vision Rehabilitation Services, Allegheny General Hospital, Pittsburgh, Pennsylvania; Clinical Professor, University of the Incarnate Word, Rosenberg School of Optometry, San Antonio, TexasDr. Paul B. Freeman is the Chief of Low Vision Rehabilitation Services at Allegheny General Hospital in Pittsburgh, Pennsylvania, and he provides low vision rehabilitation services at Keystone Blind Association in Hermitage, Pennsylvania, and at Beaver County Association for the Blind in Conway, Pennsylvania. Dr. Freeman is also a Clinical Professor at the University of the Incarnate Word, Rosenberg School of Optometry in San Antonio, Texas.
Dr. Freeman’s clinical interests include visual impairment, traumatic brain injury, visual aspects of driving, and learning-related vision problems. He has been an investigator in a number of vision research projects to determine the efficacy of sophisticated low vision devices, to assess the psychological implications of low vision, and to explore the relationship of vision and the learning process.
A Fellow of the American Academy of Optometry and a Diplomate in Low Vision, Dr. Freeman is also a Fellow of Optometric Vision Development and Rehabilitation Association. He lectures both nationally and internationally and has authored numerous articles and book chapters. Currently, he is Editor-in-Chief of Optometric Clinical Practice.
Recent Contributions to PracticeUpdate:
- Quality of Life and Functional Vision in Children With Glaucoma
- Multimodal Imaging of Suspicious Choroidal Neoplasms in a Primary Eye-Care Clinic
- Real-World Vision Test Performance With Dry Age-Related Macular Degeneration
- Fellow Eye Deficits in Amblyopia
- Risk for Low Visual Acuity in Neovascular AMD After 1 or 2 Years of Anti-VEGF Treatment
- Benign Yellow Dot Maculopathy: A New Macular Phenotype
- Relationship of Self-Reported Function to Visual Field Findings
- Orthokeratology vs Soft Contact Lenses in Near Binocular Visual Function
- Performance of the Spot Vision Screener in Children Younger Than Three Years
- Experience of Anti-VEGF Treatment and Depression and Anxiety in Patients With Wet AMD